Premium
P1–069: Hippocampal subregion–specific upregulation of alpha 7 nicotinic acetylcholine receptors and striatal–enriched phosphatase in APP transgenic mice
Author(s) -
Chin Jeannie,
Palop Jorge J.,
Cheng Jason S.,
Yu Gui-Qiu,
Mucke Lennart
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.444
Subject(s) - dentate gyrus , hippocampal formation , neuroscience , nicotinic agonist , acetylcholine receptor , genetically modified mouse , endocrinology , transgene , biology , medicine , receptor , microbiology and biotechnology , biochemistry , gene
a compound that elevates cGMP levels by inhibiting phosphodiesterase 5, has a beneficial effect on synaptic and cognitive deficits in APP/PS1 mice. Methods: Basal synaptic transmission (BST) and LTP were recorded at the CA3-CA1 hippocampal connection. Contextual learning and spatial working memory were studied through fear conditioning and radial-arm watermaze, respectively. CREB phosphorylation was analyzed on slices used for electrophysiology. Results: A brief 10 min application of sildenafil (1 M), synthesized as previously reported (Terrett et al, Bioorg Med Chem Lett. 1996, 6:1819), re-established normal potentiation and CREB phosphorylation in 3 month-old APP/PS1 slices. A single injection of sildenafil (3mg/kg, i.p.) also improved contextual and spatial working memory in the double transgenic mice. Sildenafil was also capable of maintaining its protective effect over a prolonged period of time. Both APP/PS1 and WT mice were injected with sildenafil (3 mg/kg/day, ip) for 3 weeks, then the treatment was stopped for 9-12 weeks prior to testing. Mice were next subjected to the radial-arm water-maze task and re-tested for contextual learning. Results revealed a strong effect of treatment in APP/PS1 mice treated with sildenafil compared to APP/PS1 animals treated with vehicle. Electrophysiological studies showed an improvement of both BST and LTP in sildenafil-treated APP/PS1 mice; immunocytochemistry for phospho-CREB confirmed the beneficial effect of sildenafil in the transgenic mice. Conclusions: Sildenafil treatment ameliorates synaptic and cognitive dysfunction in AD mouse model.